Immunohistochemical Expression of SNAI1 Correlates With Tumor Grade, Stage and Biochemical Disease Recurrence in Prostatic Adenocarcinomas (PACs)

被引：0
|
作者：
Rand, Janne
Ainechi, Sanaz
Middleton, Dion
Nazeer, Tipu
Kallakury, Bhaskar
Sheehan, Christine
Ross, Jeffrey
机构：
[1] Albany Med Coll, Albany, NY 12208 USA
[2] Georgetown Univ Hosp, Washington, DC 20007 USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1006
引用
收藏
页码：253A / 253A
页数：1
相关论文
共 31 条
  • [21] Relationship of p21WAF1 expression with disease-free survival and biochemical recurrence in prostate adenocarcinomas (PCa)
    Sarkar, FH
    Li, YW
    Sakr, WA
    Grignon, DJ
    Madan, SS
    Wood, DP
    Adsay, V
    PROSTATE, 1999, 40 (04): : 256 - 260
  • [22] Prostatic Ductal Adenocarcinoma Controlled for Tumor Grade, Stage, and Margin Status Does Not Independently Influence the Likelihood of Biochemical Recurrence in Localized Prostate Cancer After Radical Prostatectomy
    Kryvenko, Oleksandr N.
    Iakymenko, Oleksii A.
    Guido, Luiz P. De Lima
    Bhattu, Amit S.
    Merhe, Ali
    Mouzannar, Ali
    Briski, Laurence M.
    Oymagil, Irfan
    Lugo, Isabella
    Nemov, Ivan
    Ritch, Chad R.
    Kava, Bruce R.
    Punnen, Sanoj
    Jorda, Merce
    Parekh, Dipen J.
    Gonzalgo, Mark L.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2022, 146 (08) : 1012 - 1017
  • [23] Relationship of P21 (WAF1) expression with disease free survival and biochemical recurrence in prostatic adenocarcinoma.
    Sarkar, F
    Sakr, W
    Grignon, D
    Bianco, F
    Powell, I
    Wood, D
    Adsay, V
    LABORATORY INVESTIGATION, 1999, 79 (01) : 106A - 106A
  • [24] Increased RASSF1 C Expression Correlates with Tumor Recurrence and Shorter Patient Survival in High-Grade Pulmonary Neuroendocrine Carcinomas
    Pelosi, G.
    Fumagalli, C.
    Sonzogni, A.
    Maisonneuve, P.
    Del Curto, B.
    Manzotti, M.
    Galetta, D.
    Viale, G.
    MODERN PATHOLOGY, 2009, 22 : 359A - 359A
  • [25] Increased RASSF1 C Expression Correlates with Tumor Recurrence and Shorter Patient Survival in High-Grade Pulmonary Neuroendocrine Carcinomas
    Pelosi, G.
    Fumagalli, C.
    Sonzogni, A.
    Maisonneuve, P.
    Del Curto, B.
    Manzotti, M.
    Galetta, D.
    Viale, G.
    LABORATORY INVESTIGATION, 2009, 89 : 359A - 359A
  • [26] Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas
    Driver, Brandon R.
    Miller, Ross A.
    Miller, Tara
    Deavers, Michael
    Gorman, Blythe
    Mody, Dina
    Ge, Yimin
    Barrios, Roberto
    Bernicker, Eric
    Kim, Min
    Cagle, Philip T.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (11) : 1529 - 1532
  • [27] No Association between BRCA1 Immunohistochemical Expression and Tumor Grade, Stage or Overall Survival in Platinum-Treated Epithelial Ovarian Cancer Patients
    Shawky, Abd El-Aty
    Abd El-Hafez, Amal
    El-Tantawy, Dina
    Hamdy, Rasha
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (10) : 4275 - 4279
  • [28] The relationship between the expression of E-cadherin and tumor recurrence and progression in high-grade stage T1 bladder urothelial carcinoma
    Fikret Erdemir
    Faruk Ozcan
    Isin Kılıcaslan
    Bekir S. Parlaktas
    Nihat Uluocak
    Ozgur Gokce
    International Urology and Nephrology, 2007, 39 : 1031 - 1037
  • [29] The relationship between the expression of E-cadherin and tumor recurrence and progression in high-grade stage T1 bladder urothelial carcinoma
    Erdemir, Fikret
    Ozcan, Faruk
    Kilicaslan, Isin
    Parlaktas, Bekir S.
    Uluocak, Nihat
    Gokce, Ozgur
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2007, 39 (04) : 1031 - 1037
  • [30] Loss of p27KIP1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers
    Sgambato, A
    Migaldi, M
    Faraglia, B
    Garagnani, L
    Romano, G
    De Gaetani, C
    Ferrari, P
    Capelli, G
    Trentini, GP
    Cittadini, A
    CANCER RESEARCH, 1999, 59 (13) : 3245 - 3250
1234